Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what representations he has made to his EU counterparts on the presence of the European Medicines Agency in the UK after the UK leaves the EU.

The European Medicines Agency’s (EMA) future location is not an issue that falls within the United Kingdom’s own competence but will be decided by the 27 remaining European Union member states. The Government is fully assessing how the UK’s decision to leave the European Union will impact on medicines regulation in the UK, including the potential relocation of the EMA. Whatever the future relationship between the UK and EMA, the Government will work to ensure that patient access to medicines will not be adversely impacted.